RNA whole-transcriptome sequencing test informs thyroid cancer treatment decisions at time of diagnosis

September 17, 2019 Leave a comment 2,062 Views

Veracyte, Inc. (Nasdaq: VCYT) today announced the publication of new data demonstrating the clinical and analytical validity of its Afirma® Xpression Atlas (XA) genomic test, which is used to help guide surgery and treatment decisions for patients with likely or confirmed ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Afirma® Xpression Atlas

RNA whole-transcriptome sequencing test informs thyroid cancer treatment decisions at time of diagnosis

SiT – spatial isoform transcriptomics

Analysis of single-cell rna-seq data

AllenDigger – spatial expression data visualization, spatial heterogeneity delineation, and single-cell registration based on the Allen Brain Atlas

New research identifies an inaccuracy in the single cell GENCODE gene model

Femtosecond laser microdissection for isolation of regenerating C. elegans neurons for single-cell RNA sequencing

Spatial epigenome–transcriptome co-profiling of mammalian tissues

A protocol for single nucleus RNA-seq from frozen skeletal muscle